| |
Remark |
 G Protein-coupled receptors
|
|
|
Cytokine receptors
|
|
|
Nuclear receptors
|
|
|
 Ion channels
|
Cys-loop superfamily
|
Glutamate-gated cation channels
|
Epithelial and related channels
|
Ryanodine and IP3 receptors
|
Voltage-gated cation channels
|
Na+ channel, SCN alpha, NaV1.x
|
voltage-gated sodium channel (SCN1A) [HSA:6323] [KO:K04833]
|
Quinidine [ATC:C01BA01]
|
Procainamide [ATC:C01BA02]
|
Disopyramide [ATC:C01BA03]
|
Ajmaline [ATC:C01BA05]
|
Lidocaine [ATC:C01BB01 C05AD01 D04AB01]
|
Mexiletine [ATC:C01BB02]
|
Tocainide [ATC:C01BB03]
|
Aprindine [ATC:C01BB04]
|
Propafenone [ATC:C01BC03]
|
Flecainide [ATC:C01BC04]
|
Encainide [ATC:C01BC08]
|
Moracizine [ATC:C01BG01]
|
Cibenzoline [ATC:C01BG07]
|
Tetracaine [ATC:C05AD02 D04AB06 N01BA03 S01HA03]
|
Benzocaine [ATC:C05AD03 D02BA01 D04AB04 N01BA05 R02AD01]
|
Cinchocaine [ATC:C05AD04 D04AB02 N01BB06 S01HA06]
|
Procaine [ATC:C05AD05 N01BA02 S01HA05]
|
Aminobenzoic acid [ATC:D02BA01]
|
Chloroprocaine [ATC:N01BA04]
|
Bupivacaine [ATC:N01BB01]
|
Mepivacaine [ATC:N01BB03]
|
Ropivacaine [ATC:N01BB09]
|
Levobupivacaine [ATC:N01BB10]
|
Phenytoin [ATC:N03AB02]
|
 D00512 Phenytoin (JP16/USP/INN)
D02103 Phenytoin sodium (USP)
|
Blocker
Blocker
|
Mephenytoin [ATC:N03AB04]
|
Fosphenytoin [ATC:N03AB05]
|
Carbamazepine [ATC:N03AF01]
|
Oxcarbazepine [ATC:N03AF02]
|
Eslicarbazepine [ATC:N03AF04]
|
Lamotrigine [ATC:N03AX09]
|
Topiramate [ATC:N03AX11]
|
Zonisamide [ATC:N03AX15]
|
Cocaine [ATC:N01BC01 R02AD03 S01HA01 S02DA02]
|
Dyclonine [ATC:R02AD04]
|
Ambroxol [ATC:R05CB06]
|
Hydroquinidine
|
Pilsicainide
|
Pirmenol
|
Proparacaine
|
voltage-gated sodium channel (SCN2A) [HSA:6326] [KO:K04834]
|
Quinidine [ATC:C01BA01]
|
Procainamide [ATC:C01BA02]
|
Disopyramide [ATC:C01BA03]
|
Ajmaline [ATC:C01BA05]
|
Lidocaine [ATC:C01BB01 C05AD01 D04AB01]
|
Mexiletine [ATC:C01BB02]
|
Tocainide [ATC:C01BB03]
|
Aprindine [ATC:C01BB04]
|
Propafenone [ATC:C01BC03]
|
Flecainide [ATC:C01BC04]
|
Encainide [ATC:C01BC08]
|
Moracizine [ATC:C01BG01]
|
Cibenzoline [ATC:C01BG07]
|
Tetracaine [ATC:C05AD02 D04AB06 N01BA03 S01HA03]
|
Benzocaine [ATC:C05AD03 D02BA01 D04AB04 N01BA05 R02AD01]
|
Cinchocaine [ATC:C05AD04 D04AB02 N01BB06 S01HA06]
|
Procaine [ATC:C05AD05 N01BA02 S01HA05]
|
Aminobenzoic acid [ATC:D02BA01]
|
Chloroprocaine [ATC:N01BA04]
|
Bupivacaine [ATC:N01BB01]
|
Mepivacaine [ATC:N01BB03]
|
Ropivacaine [ATC:N01BB09]
|
Levobupivacaine [ATC:N01BB10]
|
Phenytoin [ATC:N03AB02]
|
D00512 Phenytoin (JP16/USP/INN)
D02103 Phenytoin sodium (USP)
|
Blocker
Blocker
|
Mephenytoin [ATC:N03AB04]
|
Fosphenytoin [ATC:N03AB05]
|
Carbamazepine [ATC:N03AF01]
|
Oxcarbazepine [ATC:N03AF02]
|
Eslicarbazepine [ATC:N03AF04]
|
Lamotrigine [ATC:N03AX09]
|
Topiramate [ATC:N03AX11]
|
Zonisamide [ATC:N03AX15]
|
Cocaine [ATC:N01BC01 R02AD03 S01HA01 S02DA02]
|
Dyclonine [ATC:R02AD04]
|
Ambroxol [ATC:R05CB06]
|
Hydroquinidine
|
Pilsicainide
|
Pirmenol
|
Proparacaine
|
voltage-gated sodium channel (SCN3A) [HSA:6328] [KO:K04836]
|
Quinidine [ATC:C01BA01]
|
Procainamide [ATC:C01BA02]
|
Disopyramide [ATC:C01BA03]
|
Ajmaline [ATC:C01BA05]
|
Lidocaine [ATC:C01BB01 C05AD01 D04AB01]
|
Mexiletine [ATC:C01BB02]
|
Tocainide [ATC:C01BB03]
|
Aprindine [ATC:C01BB04]
|
Propafenone [ATC:C01BC03]
|
Flecainide [ATC:C01BC04]
|
Encainide [ATC:C01BC08]
|
Moracizine [ATC:C01BG01]
|
Cibenzoline [ATC:C01BG07]
|
Tetracaine [ATC:C05AD02 D04AB06 N01BA03 S01HA03]
|
Benzocaine [ATC:C05AD03 D02BA01 D04AB04 N01BA05 R02AD01]
|
Cinchocaine [ATC:C05AD04 D04AB02 N01BB06 S01HA06]
|
Procaine [ATC:C05AD05 N01BA02 S01HA05]
|
Aminobenzoic acid [ATC:D02BA01]
|
Chloroprocaine [ATC:N01BA04]
|
Bupivacaine [ATC:N01BB01]
|
Mepivacaine [ATC:N01BB03]
|
Ropivacaine [ATC:N01BB09]
|
Levobupivacaine [ATC:N01BB10]
|
Phenytoin [ATC:N03AB02]
|
D00512 Phenytoin (JP16/USP/INN)
D02103 Phenytoin sodium (USP)
|
Blocker
Blocker
|
Mephenytoin [ATC:N03AB04]
|
Fosphenytoin [ATC:N03AB05]
|
Carbamazepine [ATC:N03AF01]
|
Oxcarbazepine [ATC:N03AF02]
|
Eslicarbazepine [ATC:N03AF04]
|
Lamotrigine [ATC:N03AX09]
|
Topiramate [ATC:N03AX11]
|
Zonisamide [ATC:N03AX15]
|
Cocaine [ATC:N01BC01 R02AD03 S01HA01 S02DA02]
|
Dyclonine [ATC:R02AD04]
|
Ambroxol [ATC:R05CB06]
|
Hydroquinidine
|
Pilsicainide
|
Pirmenol
|
Proparacaine
|
voltage-gated sodium channel (SCN4A) [HSA:6329] [KO:K04837]
|
Quinidine [ATC:C01BA01]
|
Procainamide [ATC:C01BA02]
|
Disopyramide [ATC:C01BA03]
|
Ajmaline [ATC:C01BA05]
|
Lidocaine [ATC:C01BB01 C05AD01 D04AB01]
|
Mexiletine [ATC:C01BB02]
|
Tocainide [ATC:C01BB03]
|
Aprindine [ATC:C01BB04]
|
Propafenone [ATC:C01BC03]
|
Flecainide [ATC:C01BC04]
|
Encainide [ATC:C01BC08]
|
Moracizine [ATC:C01BG01]
|
Cibenzoline [ATC:C01BG07]
|
Tetracaine [ATC:C05AD02 D04AB06 N01BA03 S01HA03]
|
Benzocaine [ATC:C05AD03 D02BA01 D04AB04 N01BA05 R02AD01]
|
Cinchocaine [ATC:C05AD04 D04AB02 N01BB06 S01HA06]
|
Procaine [ATC:C05AD05 N01BA02 S01HA05]
|
Aminobenzoic acid [ATC:D02BA01]
|
Chloroprocaine [ATC:N01BA04]
|
Bupivacaine [ATC:N01BB01]
|
Mepivacaine [ATC:N01BB03]
|
Ropivacaine [ATC:N01BB09]
|
Levobupivacaine [ATC:N01BB10]
|
Phenytoin [ATC:N03AB02]
|
D00512 Phenytoin (JP16/USP/INN)
D02103 Phenytoin sodium (USP)
|
Blocker
Blocker
|
Mephenytoin [ATC:N03AB04]
|
Fosphenytoin [ATC:N03AB05]
|
Carbamazepine [ATC:N03AF01]
|
Oxcarbazepine [ATC:N03AF02]
|
Eslicarbazepine [ATC:N03AF04]
|
Lamotrigine [ATC:N03AX09]
|
Topiramate [ATC:N03AX11]
|
Zonisamide [ATC:N03AX15]
|
Cocaine [ATC:N01BC01 R02AD03 S01HA01 S02DA02]
|
Dyclonine [ATC:R02AD04]
|
Ambroxol [ATC:R05CB06]
|
Hydroquinidine
|
Pilsicainide
|
Pirmenol
|
Proparacaine
|
voltage-gated sodium channel (SCN5A) [HSA:6331] [KO:K04838]
|
Quinidine [ATC:C01BA01]
|
Procainamide [ATC:C01BA02]
|
Disopyramide [ATC:C01BA03]
|
Ajmaline [ATC:C01BA05]
|
Lidocaine [ATC:C01BB01 C05AD01 D04AB01]
|
Mexiletine [ATC:C01BB02]
|
Tocainide [ATC:C01BB03]
|
Aprindine [ATC:C01BB04]
|
Propafenone [ATC:C01BC03]
|
Flecainide [ATC:C01BC04]
|
Encainide [ATC:C01BC08]
|
Moracizine [ATC:C01BG01]
|
Cibenzoline [ATC:C01BG07]
|
Tetracaine [ATC:C05AD02 D04AB06 N01BA03 S01HA03]
|
Benzocaine [ATC:C05AD03 D02BA01 D04AB04 N01BA05 R02AD01]
|
Cinchocaine [ATC:C05AD04 D04AB02 N01BB06 S01HA06]
|
Procaine [ATC:C05AD05 N01BA02 S01HA05]
|
Aminobenzoic acid [ATC:D02BA01]
|
Chloroprocaine [ATC:N01BA04]
|
Bupivacaine [ATC:N01BB01]
|
Mepivacaine [ATC:N01BB03]
|
Ropivacaine [ATC:N01BB09]
|
Levobupivacaine [ATC:N01BB10]
|
Phenytoin [ATC:N03AB02]
|
D00512 Phenytoin (JP16/USP/INN)
D02103 Phenytoin sodium (USP)
|
Blocker
Blocker
|
Mephenytoin [ATC:N03AB04]
|
Fosphenytoin [ATC:N03AB05]
|
Carbamazepine [ATC:N03AF01]
|
Oxcarbazepine [ATC:N03AF02]
|
Eslicarbazepine [ATC:N03AF04]
|
Lamotrigine [ATC:N03AX09]
|
Topiramate [ATC:N03AX11]
|
Zonisamide [ATC:N03AX15]
|
Cocaine [ATC:N01BC01 R02AD03 S01HA01 S02DA02]
|
Dyclonine [ATC:R02AD04]
|
Ambroxol [ATC:R05CB06]
|
Hydroquinidine
|
Pilsicainide
|
Pirmenol
|
Proparacaine
|
voltage-gated sodium channel (SCN8A) [HSA:6334] [KO:K04840]
|
Quinidine [ATC:C01BA01]
|
Procainamide [ATC:C01BA02]
|
Disopyramide [ATC:C01BA03]
|
Ajmaline [ATC:C01BA05]
|
Lidocaine [ATC:C01BB01 C05AD01 D04AB01]
|
Mexiletine [ATC:C01BB02]
|
Tocainide [ATC:C01BB03]
|
Aprindine [ATC:C01BB04]
|
Propafenone [ATC:C01BC03]
|
Flecainide [ATC:C01BC04]
|
Encainide [ATC:C01BC08]
|
Moracizine [ATC:C01BG01]
|
Cibenzoline [ATC:C01BG07]
|
Tetracaine [ATC:C05AD02 D04AB06 N01BA03 S01HA03]
|
Benzocaine [ATC:C05AD03 D02BA01 D04AB04 N01BA05 R02AD01]
|
Cinchocaine [ATC:C05AD04 D04AB02 N01BB06 S01HA06]
|
Procaine [ATC:C05AD05 N01BA02 S01HA05]
|
Aminobenzoic acid [ATC:D02BA01]
|
Chloroprocaine [ATC:N01BA04]
|
Bupivacaine [ATC:N01BB01]
|
Mepivacaine [ATC:N01BB03]
|
Ropivacaine [ATC:N01BB09]
|
Levobupivacaine [ATC:N01BB10]
|
Phenytoin [ATC:N03AB02]
|
D00512 Phenytoin (JP16/USP/INN)
D02103 Phenytoin sodium (USP)
|
Blocker
Blocker
|
Mephenytoin [ATC:N03AB04]
|
Fosphenytoin [ATC:N03AB05]
|
Carbamazepine [ATC:N03AF01]
|
Oxcarbazepine [ATC:N03AF02]
|
Eslicarbazepine [ATC:N03AF04]
|
Lamotrigine [ATC:N03AX09]
|
Topiramate [ATC:N03AX11]
|
Zonisamide [ATC:N03AX15]
|
Cocaine [ATC:N01BC01 R02AD03 S01HA01 S02DA02]
|
Dyclonine [ATC:R02AD04]
|
Ambroxol [ATC:R05CB06]
|
Hydroquinidine
|
Pilsicainide
|
Pirmenol
|
Proparacaine
|
voltage-gated sodium channel (SCN9A) [HSA:6335] [KO:K04841]
|
Quinidine [ATC:C01BA01]
|
Procainamide [ATC:C01BA02]
|
Disopyramide [ATC:C01BA03]
|
Ajmaline [ATC:C01BA05]
|
Lidocaine [ATC:C01BB01 C05AD01 D04AB01]
|
Mexiletine [ATC:C01BB02]
|
Tocainide [ATC:C01BB03]
|
Aprindine [ATC:C01BB04]
|
Propafenone [ATC:C01BC03]
|
Flecainide [ATC:C01BC04]
|
Encainide [ATC:C01BC08]
|
Moracizine [ATC:C01BG01]
|
Cibenzoline [ATC:C01BG07]
|
Tetracaine [ATC:C05AD02 D04AB06 N01BA03 S01HA03]
|
Benzocaine [ATC:C05AD03 D02BA01 D04AB04 N01BA05 R02AD01]
|
Cinchocaine [ATC:C05AD04 D04AB02 N01BB06 S01HA06]
|
Procaine [ATC:C05AD05 N01BA02 S01HA05]
|
Aminobenzoic acid [ATC:D02BA01]
|
Chloroprocaine [ATC:N01BA04]
|
Bupivacaine [ATC:N01BB01]
|
Mepivacaine [ATC:N01BB03]
|
Ropivacaine [ATC:N01BB09]
|
Levobupivacaine [ATC:N01BB10]
|
Phenytoin [ATC:N03AB02]
|
D00512 Phenytoin (JP16/USP/INN)
D02103 Phenytoin sodium (USP)
|
Blocker
Blocker
|
Mephenytoin [ATC:N03AB04]
|
Fosphenytoin [ATC:N03AB05]
|
Carbamazepine [ATC:N03AF01]
|
Oxcarbazepine [ATC:N03AF02]
|
Eslicarbazepine [ATC:N03AF04]
|
Lamotrigine [ATC:N03AX09]
|
Topiramate [ATC:N03AX11]
|
Zonisamide [ATC:N03AX15]
|
Cocaine [ATC:N01BC01 R02AD03 S01HA01 S02DA02]
|
Dyclonine [ATC:R02AD04]
|
Ambroxol [ATC:R05CB06]
|
Hydroquinidine
|
Pilsicainide
|
Pirmenol
|
Proparacaine
|
voltage-gated sodium channel (SCN10A) [HSA:6336] [KO:K04842]
|
voltage-gated sodium channel
|
sodium channel
|
Ca2+ channel, CACN alpha-1, CaVx.x
|
K+ channel, KCNA, Kv1.x (Shaker)
|
K+ channel, KCNC, Kv3.x (Shaw)
|
K+ channel, KCND, Kv4.x (Shal)
|
K+ channel, KCNQ, Kv7.x (KQT-like)
|
K+ channel, KCNH, Kv10-12.x (Ether-a-go-go)
|
K+ channel, KCNK, K2px.x
|
Related to voltage-gated cation channels
|
Chloride channels
|
|
|
Transporters
|
|
|
Enzymes
|
|
|
Protein kinases
|
|
|
Cytokines
|
|
|
Others
|
Target-based Classification of Drugs